2019 Volume 65 Issue 5 Pages 782-792
It is very important to perform irregular antibody screening to ensure safe and efficient red blood cell transfusion. In this study, we developed a new method to detect IgG class irregular antibodies by flow cytometry using anti-human IgG as a secondary antibody (Flow Cytometry Irregular Antibody Screening: FCM-SC). The mean fluorescence intensity ratio of the patient sample to negative sample (S/N) was estimated. The result was considered positive if S/N was greater than 1.7. For clinically significant antibodies like anti-E and anti-S, 12 out of 95 cases with Column Agglutination Technology (CAT) positive results were FCM-SC negative, and additional testing by PEG-IAT confirmed the negative results. 22 out of 29 cases that were anti-M and anti-Lea antibody positive by CAT were FCM-SC negative, and additional testing by IAT without enhancement media revealed that all cases were negative. 9 out of 33 cases that did not show reaction specificity by CAT, such as by autoantibody and cold agglutination, were FCM-SC negative, and additional testing by PEG-IAT using plasma that had been treated with a reducing agent also showed negative results. These results suggest that FCM-SC is a useful method for detecting IgG class irregular antibodies and may be suitable for antibody screening.